Infratil has this morning released the presentation material for its annual Investor Day. Presentations will be recorded during the day and will be available to view on https://infratil.com/investors/reports-results-meetings-investor-days/ after the event.
Infratil's objective is to keep its stakeholders well informed about how its businesses are performing and how their delivery of strategic objectives is progressing.
Management will provide an update on Infratil's portfolio strategy, as well as providing views on the near-term outlook. There will also be a number of presentations from senior executives at Infratil’s portfolio businesses, including Qscan Group, RHCNZ Medical Imaging, Longroad Energy, CDC Data Centres, and Vodafone (One NZ).
Infratil has also narrowed its Proportionate EBITDAF guidance range for the year ended 31 March 2023 to $520 million to $535 million (previously $510 to $540 million).
Any enquiries should be directed to:
Any investor enquiries should be directed to:
Mark Flesher
Investor Relations
Email: mark.flesher@infratil.com
- 1. Infratil Investor Day 2023 - Portfolio Update & Outlook (PDF, 1.88MB)
- 2. Infratil Investor Day 2023 - Sector Overviews (PDF, 2.36MB)
- 3. Infratil Investor Day 2023 - CDC Data Centres Update (PDF, 1.13MB)
- 4. Infratil Investor Day 2023 - Longroad Energy Update (PDF, 3.14MB)
- 5. Infratil Investor Day 2023 - Manawa Energy Update (PDF, 1.48MB)
- 6. Infratil Investor Day 2023 - Qscan Group Update (PDF, 1.39MB)
- 7. Infratil Investor Day 2023 - RetireAustralia Update (PDF, 416.85KB)
- 8. Infratil Investor Day 2023 - RHCNZ Medical Imaging Update (PDF, 765.76KB)
- 9. Infratil Investor Day 2023 - Vodafone Update (PDF, 1.42MB)
- 10. Infratil Investor Day 2023 - Wellington Airport Update (PDF, 1.27MB)
Related
Australian data centre update
Infratil Limited (NZX/ASX:IFT) notes it has recently received a number of investor queries regarding power delivery timelines for under-construction sites in Australia. CDC has confirmed that it has robust delivery
Infratil Newsletter - October 2026
Attached is a copy of the latest Infratil Newsletter for investors, with commentary on our recent Investor Day and developments at various portfolio companies. Enquiries should be directed to: Brett
CDC Independent Valuation – 30 September 2026
CDC Independent Valuation – 30 September 2026 CDC’s independent valuation was broadly flat with a mid-point valuation of A$18.5 billion at 30 September 2026. Continued progress in customer contracting and